Home » Stocks » MD

MEDNAX, Inc. (MD)

Stock Price: $24.43 USD 0.46 (1.92%)
Updated Feb 26, 2021 4:00 PM EST - Market closed
Pre-market: $24.93 +0.50 (2.05%) Mar 1, 7:00 AM
Market Cap 2.09B
Revenue (ttm) 1.73B
Net Income (ttm) -796.49M
Shares Out 83.40M
EPS (ttm) -9.55
PE Ratio n/a
Forward PE 15.70
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $24.43
Previous Close $23.97
Change ($) 0.46
Change (%) 1.92%
Day's Open 23.87
Day's Range 23.81 - 24.89
Day's Volume 936,534
52-Week Range 7.37 - 29.26

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 1 week ago

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax to Present at Upcoming Investor Conferences

Zacks Investment Research - 1 week ago

MEDNAX's (MD) fourth-quarter results reflect muted revenues caused by the COVID-19 pandemic.

The Motley Fool - 1 week ago

The company released its earnings report for the fourth quarter.

Zacks Investment Research - 1 week ago

Mednax (MD) delivered earnings and revenue surprises of -19.35% and -8.64%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 1 week ago

Shares of Mednax (NYSE:MD) fell 0.2% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 72.53% year over year to $0.25, which missed th...

Business Wire - 1 week ago

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax Reports Fourth Quarter Results

Business Wire - 3 weeks ago

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax 2020 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 18, 2021

Business Wire - 1 month ago

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- #neoconference2021--The virtual NEO conference will continue its longstanding tradition of addressing key areas of neonatal management to improve newbo...

Business Wire - 1 month ago

OKLAHOMA CITY--(BUSINESS WIRE)-- #FedermanSherwood--Federman & Sherwood Files First Data Breach Case Against MedNax, Inc. and Pediatrix Medical Group, a MedNax Company

Zacks Investment Research - 1 month ago

Riding high on its strategic efforts and cost-cutting measures, MEDNAX (MD) holds enough potential to reap benefits for investors.

Business Wire - 2 months ago

EL SEGUNDO, Calif.--(BUSINESS WIRE)-- #PracticeNotCompany--Radiology Partners (RP), the leading radiology practice in the U.S., today announced the completion of its acquisition of MEDNAX Radi...

Business Wire - 2 months ago

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--MEDNAX Completes Sale of MEDNAX Radiology Solutions to Radiology Partners

Zacks Investment Research - 2 months ago

Mednax (MD) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 3 months ago

MEDNAX's (MD) third-quarter results reflect muted revenues and high costs, partly offset by lower interest expense.

Seeking Alpha - 3 months ago

MEDNAX, Inc. (MD) CEO Mark Ordan on Q3 2020 Results - Earnings Call Transcript

Benzinga - 3 months ago

Shares of Mednax (NYSE:MD) rose 5.3% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share fell 59.34% year over year to $0.37, which missed the est...

Zacks Investment Research - 3 months ago

Mednax (MD) delivered earnings and revenue surprises of -7.50% and -13.87%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 3 months ago

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--MEDNAX Reports Third Quarter Results

Zacks Investment Research - 4 months ago

Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 4 months ago

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX 2020 Third Quarter Conference Call/Webcast Scheduled for Friday, November 6, 2020

CNBC Television - 5 months ago

Why this health care strategist likes the work-from-home trade

CNBC's Kelly Evans discusses the best work-from-home health care equity investments with Jared Holz of Jefferies Health Care Strategy.

Other stocks mentioned: ABBV, ABT
Zacks Investment Research - 5 months ago

Riding on restructuring as well as cost-cutting initiatives, MEDNAX (MD) holds potential to reap benefits for investors.

PRNewsWire - 5 months ago

NEW YORK, Sept. 15, 2020 /PRNewswire/ -- DLA Piper represented MEDNAX, Inc.

Zacks Investment Research - 5 months ago

MEDNAX (MD) reaches an agreement with Radiology Partners to sell its MEDNAX Radiology Solutions, which will lower its debt load and restructure its business.

Zacks Investment Research - 5 months ago

MEDNAX (MD) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Market Watch - 5 months ago

Mednax Inc. MD, +0.73% said Thursday it has reached an agreement to sell its radiology business to physician-owned Radiology Partners for $885 million in cash.

Business Wire - 5 months ago

EL SEGUNDO, Calif.--(BUSINESS WIRE)--Radiology Partners (RP), the leading radiology practice in the U.S.

Business Wire - 5 months ago

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX Announces Agreement to Sell MEDNAX Radiology Solutions to Radiology Partners

Zacks Investment Research - 6 months ago

Mednax (MD) reported earnings 30 days ago. What's next for the stock?

Business Wire - 6 months ago

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX Announces Financial Leadership Transition - C.

Seeking Alpha - 6 months ago

MEDNAX, Inc. (MD) CEO Mark Ordan on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 7 months ago

MEDNAX's (MD) Q2 results reflect lower expenses, offset by soft revenues.

Benzinga - 7 months ago

Shares of Mednax (NYSE:MD) were flat in pre-market trading after the company reported Q2 results.

Zacks Investment Research - 7 months ago

Mednax (MD) delivered earnings and revenue surprises of 113.33% and -13.83%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 7 months ago

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX Reports Second Quarter Results Results from Continuing Operations Reflect Significant Recovery in Second Half of Quarter Following Initial Disr

Zacks Investment Research - 7 months ago

Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 7 months ago

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX 2020 Second Quarter Conference Call/Webcast Scheduled for Thursday, July 30, 2020

Zacks Investment Research - 7 months ago

Pressure from the COVID-19 impact on global economy and lack of solvency make MEDNAX (MD) an unattractive bet.

Zacks Investment Research - 8 months ago

MEDNAX (MD) declares several transformational activities, which augur well for the long term.

Zacks Investment Research - 8 months ago

Mednax (MD) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 9 months ago

Even though MEDNAX (MD) endures the COVID-19 impact on global economy, it holds prospects to revive its fortunes with the help of its initiatives and strong fundamentals.

Zacks Investment Research - 9 months ago

MEDNAX's (MD) affiliate Jefferson Radiology collaborates with CDI for providing enhanced healthcare services to the Springfield community.

Zacks Investment Research - 9 months ago

MEDNAX (MD) sells its American Anesthesiology to NAPA for portfolio rationalization and averting the negative COVID-19 impact.

Seeking Alpha - 9 months ago

MEDNAX, Inc. (MD) CEO Roger Medel on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 9 months ago

MEDNAX's (MD) Q1 results reflect the coronavirus adversities that drained its revenues and volumes.

Benzinga - 9 months ago

Shares of Mednax (NYSE:MD) fell 10% after the company reported Q1 results. Quarterly Results Earnings per share fell 50.77% over the past year to $0.32, which missed the estimate of $0.56.

Zacks Investment Research - 9 months ago

Mednax (MD) delivered earnings and revenue surprises of -23.81% and 1.29%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 10 months ago

Even though MEDNAX (MD) endures the COVID-19 impact on global economy, it holds high prospects to revive its fortunes by virtue of its solid fundamentals.

Zacks Investment Research - 10 months ago

MEDNAX (MD) takes several steps to help fight the COVID-19 pandemic.

Zacks Investment Research - 11 months ago

MEDNAX (MD) takes back its first-quarter 2020 and preliminary full-year outlook due to the COVID-19 effect.

About MD

MEDNAX, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant moth... [Read more...]

Industry
Medical Care Facilities
IPO Date
Sep 19, 1995
Stock Exchange
NYSE
Ticker Symbol
MD
Full Company Profile

Financial Performance

In 2020, MEDNAX, Inc.'s revenue was $1.73 billion, a decrease of -2.57% compared to the previous year's $1.78 billion. Losses were -$796.49 million, -46.82% less than in 2019.

Financial Statements

Analyst Forecasts

According to 11 analysts, the average rating for MEDNAX, Inc. stock is "Hold." The 12-month stock price forecast is 20.35, which is a decrease of -16.70% from the latest price.

Price Target
$20.35
(-16.70% downside)
Analyst Consensus: Hold